Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CME | Common Stock Class A | Sale | -$1.46M | -6.58K | -8.41% | $222.40 | 71.7K | Nov 5, 2021 | Direct | F1 |
transaction | CME | Common Stock Class A | Sale | -$717K | -3.24K | -4.52% | $221.46 | 68.5K | Nov 5, 2021 | Direct | F2 |
transaction | CME | Common Stock Class A | Sale | -$39.5K | -179 | -0.26% | $220.76 | 68.3K | Nov 5, 2021 | Direct | F3 |
Id | Content |
---|---|
F1 | On November 5, 2021, Mr. Durkin sold an aggregate of 6,583 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $222.141 to $222.81. The Company maintains a record of the transaction and copies will be provided upon request. |
F2 | On November 5, 2021, Mr. Durkin sold an aggregate of 3,238 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $221.022 to $221.995. The Company maintains a record of the transaction and copies will be provided upon request. |
F3 | On November 5, 2021, Mr. Durkin sold an aggregate of 179 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $220.72 to $220.78. The Company maintains a record of the transaction and copies will be provided upon request. |